market access

News

Charities bankroll coronavirus drug hunt as outbreak hits economies

Hungary steps out of line with EU to order Russia's COVID-19...

Hungary is to order a consignment of Russia’s Sputnik V COVID-19 vaccine, as the country struggles to contain the infection rate.

News

NHS set to roll out COVID-19 shot in New Year, says health s...

The UK’s NHS is ready to start rolling out a coronavirus vaccine, likely beginning in the new year, according to health secretary Matt Hancock.

News

NICE backs chemo-free CLL combination from AbbVie and Roche

Previously untreated patients with chronic lymphocytic leukaemia (CLL) in England will get a chemotherapy-free treatment option after NICE recommended NHS funding for a combination of AbbVi

News

Divided Congress paves way for drug price reforms on Biden's...

Unless president Donald Trump is successful with legal challenges, Democratic rival Joe Biden looks to have won the White House in last week’s election but faces the challenges of a divided

News

After two decades, NICE begins consultation on drug assessme...

The UK’s drug cost-effectiveness body NICE has launched a public consultation, presenting the case for change about how it assesses medicines, medical devices and diagnostics.

News

Pharma may avoid worst-case drug pricing scenario as US elec...

Pharma may have avoided a worst case scenario amid the political upheavals in the US elections with the threat of tough drug price legislation lowered, with hawkish Democrats unlikely to wi

Hungary steps out of line with EU to order Russia's COVID-19...

NHS set to roll out COVID-19 shot in New Year, says health s...

NICE backs chemo-free CLL combination from AbbVie and Roche

Divided Congress paves way for drug price reforms on Biden's...

After two decades, NICE begins consultation on drug assessme...

Pharma may avoid worst-case drug pricing scenario as US elec...

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

market access

Editor's Picks